Clinical Outcomes with β-Blockers for Myocardial Infarction: A Meta-analysis of Randomized Trials
Top Cited Papers
- 1 October 2014
- journal article
- research article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 127 (10), 939-953
- https://doi.org/10.1016/j.amjmed.2014.05.032
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive SummaryCirculation, 2013
- Are β-blockers truly helpful in patients with CAD?Nature Reviews Cardiology, 2012
- β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery DiseaseJama-Journal Of The American Medical Association, 2012
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 UpdateCirculation, 2011
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)European Heart Journal, 2011
- Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trialThe Lancet, 2005
- Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trialThe Lancet, 2001
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Effects on Mortality during Five Years after Early Intervention with Metoprolol in Suspected Acute Myocardial InfarctionActa Medica Scandinavica, 1988
- POTASSIUM, GLUCOSE, AND INSULIN IN TREATMENT OF MYOCARDIAL INFARCTIONThe Lancet, 1965